Britain's health regulator has approved Moderna's COVID-19 vaccine for use in children aged 12 to 17 years.
The approval comes more than two months after Pfizer and German partner BioNTech's COVID-19 vaccine got regulatory nod for use in children aged 12 to 15.
Moderna's vaccine was recommended for use in adolescents by European regulators in July and is awaiting US authorisation.
It is currently approved for people over the age of 18 in the UK.
Britain's Joint Committee on Vaccination and Immunisation (JCVI) gave the go-ahead on August 4 for 16 and 17-year-olds to get their first dose of Pfizer's COVID-19 vaccine ahead of schools returning in September.
JCVI will make a decision on whether the vaccine will be deployed or not.
US military says it's completed 13th consecutive night of strikes on Iran
Indian government seeks time on minister resignation demand
Israel launches military operation after deadly clash near Palestinian village
Irish police intercept car with 'significant' bomb near Northern Ireland border
Spain declares national emergency over wildfires near Madrid and in Avila
